JNJ vs MSTY: Dividend Yield, Growth & Safety Comparison
Johnson & Johnson (JNJ) from Health Care and Yieldmax MSTR Option Income Strategy ETF (MSTY) from N/A offer different dividend profiles for income-focused portfolios. MSTY offers a significantly higher 285.70% yield compared to JNJ's 2.16%, a gap of 283.54%. For dividend growth, JNJ leads with a 5-year CAGR of 5.2% versus MSTY's -72.8%. JNJ is a Dividend King with 63 years of consecutive increases.
Key Metrics Comparison
| Metric | JNJ | MSTY |
|---|
| Dividend Yield | 2.16% | 285.70% |
| Annual Dividend | $5.14 | $78.13 |
| 5-Year CAGR | 5.2% | -72.8% |
| Payout Ratio | 47% | N/A |
| Consecutive Years | 63 | 0 |
| Price | $243.53 | $24.09 |
Yield Comparison
Yieldmax MSTR Option Income Strategy ETF (MSTY) currently yields 285.70%, which is high for the broader market. That's 283.54% more than Johnson & Johnson (JNJ), which yields 2.16%. In dollar terms, MSTY pays $78.13/share annually versus JNJ's $5.14/share.
Dividend Growth
Over the past five years, JNJ has grown its dividend at a 5.2% CAGR compared to MSTY's -72.8%. JNJ: Dividend growth is slowing — the 3-year CAGR of 4.6% trails the 5-year rate of 5.2% and the 10-year rate of 5.6%. MSTY: Dividend growth has been steady, with a 3-year CAGR of -72.8% and a 5-year CAGR of -72.8% (10-year: -72.8%).
Dividend Safety
JNJ's dividend safety is rated "Safe." The payout ratio of 47% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.1x. MSTY's dividend safety is rated "Unknown." Insufficient data to assess dividend safety.
Income Comparison
A $10,000 investment in MSTY generates approximately $28570/year in dividend income, compared to $216/year from JNJ — a difference of $28354/year. At $100,000, that gap widens to $283540/year.
Verdict
- Best for income: MSTY
- Best for growth: JNJ
- Best for safety: JNJ
Frequently Asked Questions
Which has a higher dividend yield, JNJ or MSTY?
Yieldmax MSTR Option Income Strategy ETF (MSTY) has a higher dividend yield of 285.70% compared to Johnson & Johnson (JNJ) at 2.16%.
Is JNJ or MSTY a better dividend growth stock?
Johnson & Johnson has the stronger dividend growth with a 5-year CAGR of 5.2%, compared to Yieldmax MSTR Option Income Strategy ETF's -72.8%.
Which is safer for dividend income, JNJ or MSTY?
Johnson & Johnson's dividend safety is rated "Safe" while Yieldmax MSTR Option Income Strategy ETF is rated "Unknown." The payout ratio of 47% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.1x.
How much income does $10,000 in JNJ vs MSTY generate?
A $10,000 investment in JNJ generates approximately $216/year in dividends, while the same amount in MSTY generates about $28570/year.
Is JNJ or MSTY a Dividend Aristocrat?
Johnson & Johnson is a Dividend King with 63 consecutive years of increases. Yieldmax MSTR Option Income Strategy ETF does not currently qualify for aristocrat status.
JNJ vs MSTY: which is better for retirement income?
It depends on your priorities. MSTY for current income, JNJ for dividend growth, JNJ for safety. Many retirement investors hold both for diversification.
JNJ Dividend Analysis | MSTY Dividend Analysis | All Comparisons | Comparison Tool